Skip to content
Search

Latest Stories

Regulator strikes out two-year requirement as registered pharmacist for IP training in Northern Ireland

The Council of the Pharmaceutical Society NI (PSNI) to remove the two-year requirement as a registered pharmacist to have an Independent Prescriber (IP) annotation on the pharmacy register in Northern Ireland.

It has further endorsed that the two-year requirement for entry onto stand-alone pharmacist independent prescribing courses be removed and replaced with an assessment before admission, by course providers, based upon guidance provided by the regulator.


In conjunction with the Department of Health, the PSNI will now work towards a further public consultation on the necessary legislative changes.

Dr Jim Livingstone, president of the PSNI, said: “The Department of Health has set a clear direction which will see pharmacist independent prescribers becoming increasingly important in the delivery of pharmacy services in Northern Ireland. Our role is to protect the public, but we are clear that our regulatory objective should not be an unnecessary barrier to the development of the profession and enhanced services being provided to the public."

The council’s recent public consultation outlined proposals on changes to the entry requirements for standalone independent prescribing courses and annotation as an IP on the register. The proposals sought to strike a right balance between protecting the public, whilst not placing disproportionate regulatory barriers in the way of developing services.

“I am pleased that our proposals were broadly supported,” Dr Livingstone said, adding: “Removing the two-year period before being annotated on the Register is necessary to deliver wider reforms to pharmacy education. We will continue to work with the Department of Health, to move towards a public consultation on the necessary legislative changes.

“We acknowledge the feedback received, that some further clarification and guidance is required in certain areas, and we have committed to working with our colleagues in the GPhC to develop guidance for course providers and others.

“We are also committed to exploring what additional support might be needed for independent prescribers in relation to post-registration education and professional development. We will take this work on as part of our partnership with the GPhC on the UK wide post-registration assurance of practise group. Ensuring that there is appropriate engagement and involvement with local stakeholders.

“We had several excellent responses to this consultation, which raised important issues. A number of these issues related to the wider education reform agenda and are outside the immediate responsibility of the Regulator. We have, however, committed to presenting our consultation report to the Education Reform Implementation Group, which is progressing these wider reforms in Northern Ireland.”

More For You

Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less